Check-Cap Prices $12.5M Offering at $8.72, Funding MBody AI Merger
MBAI sits 99% above its 52-week low of $4.201 on light trading volume (0.2× avg).
Summary
Check-Cap has finalized terms for a $12.5 million firm commitment public offering at $8.72 per share, according to an SEC filing. The pricing is below the current market price of $8.34, indicating a discount to attract investors. Proceeds will fund the pending merger with MBody AI, which is expected to close by the end of Q3 2026. This follows the 1-for-7 reverse stock split effective August 13, 2026, which reduced the share count and adjusted the price scale. The offering is highly dilutive relative to the company's market cap of approximately $11.3 million, but it provides necessary capital to complete the merger. Investors will watch for the merger closing and any further financing needs.
At the time of this announcement, MBAI was trading at $8.34 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $11.3M. The 52-week trading range was $4.20 to $27.44. This news item was assessed with negative market sentiment and an importance score of 7 out of 10. Source: Reuters.